To gain additional insight into how CAR4 T cells contribute to tumor destruction, we performed intravital imaging of the bone marrow in mice with established pro-B-cell tumors and treated with WT or IFN-γ−/− or perforin-deficient (Prf1−/−) CAR4 T cells. The gene discussed is IFNG; the disease is neoplasm.